Focus Partners Advisor Solutions LLC Acquires Shares of 13,430 Danaher Corporation $DHR

Focus Partners Advisor Solutions LLC bought a new position in shares of Danaher Corporation (NYSE:DHR – Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor bought 13,430 shares of the conglomerate’s stock, valued at approximately $2,558,000.

Several other hedge funds have also modified their holdings of DHR. Norges Bank acquired a new stake in shares of Danaher in the fourth quarter valued at approximately $2,177,106,000. Viking Global Investors LP lifted its holdings in Danaher by 543.9% during the 2nd quarter. Viking Global Investors LP now owns 2,907,515 shares of the conglomerate’s stock worth $574,351,000 after buying an additional 2,455,994 shares in the last quarter. Wellington Management Group LLP boosted its position in Danaher by 11.2% in the 4th quarter. Wellington Management Group LLP now owns 15,076,796 shares of the conglomerate’s stock valued at $3,451,380,000 after buying an additional 1,517,904 shares during the last quarter. Capital International Investors boosted its position in Danaher by 8.9% in the 4th quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after buying an additional 1,487,768 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD increased its stake in shares of Danaher by 9.1% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 15,973,240 shares of the conglomerate’s stock valued at $3,656,595,000 after buying an additional 1,334,221 shares during the period. 79.05% of the stock is owned by institutional investors.

Get Danaher alerts:

Danaher Stock Performance

DHR stock opened at $202.51 on Friday. Danaher Corporation has a twelve month low of $160.93 and a twelve month high of $242.80. The company has a quick ratio of 1.25, a current ratio of 1.65 and a debt-to-equity ratio of 0.48. The company has a market cap of $142.37 billion, a P/E ratio of 35.97, a price-to-earnings-growth ratio of 2.52 and a beta of 0.78. The business’s fifty day moving average is $193.14 and its 200-day moving average is $193.21.

Danaher (NYSE:DHR – Get Free Report) last announced its quarterly earnings data on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, topping analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to analysts’ expectations of $6.12 billion. Danaher had a return on equity of 11.04% and a net margin of 15.95%.The firm’s quarterly revenue was up 5.5% compared to the same quarter last year. During the same period in the previous year, the firm earned $0.77 earnings per share. Equities research analysts forecast that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on DHR. Stifel Nicolaus dropped their target price on Danaher from $260.00 to $220.00 and set a “buy” rating for the company in a research report on Wednesday, July 22nd. Citigroup started coverage on Danaher in a report on Tuesday, May 26th. They issued a “buy” rating and a $230.00 price target on the stock. Evercore reiterated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. DZ Bank began coverage on Danaher in a report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective for the company. Finally, Morgan Stanley cut their target price on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have issued a Hold rating to the stock. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus price target of $228.91.

Get Our Latest Analysis on DHR

About Danaher

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Further Reading

• Five stocks we like better than Danaher
• Is Best Buy the AI Winner Hiding in the Electronics Aisle?
• Applied Materials Beat Everything but Wall Street’s Expectations for Margins
• Back From Orbit, Intuitive Machines’ Share Price Enters the Buy Zone
• Texas Roadhouse and Brinker International Have the Recipe Rivals Are Missing

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR – Free Report).

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.